← Evidence map

ReviewMolecular cancer therapeutics2012

Mesothelin-targeted agents in clinical trials and in preclinical development.

Ronan J Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

68 papers cite itlatest 60 shown

2012
…
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22351743